Submitted by Anonymous (not verified) on 4 December 2023 - 14:28
Human medicines European public assessment report (EPAR): Rilutek, riluzole, Amyotrophic Lateral Sclerosis, Date of authorisation: 10/06/1996, Revision: 32, Status: Authorised
Source: